RxDoctor Payments Data

James Sudberry, DPM

Podiatrist · Smyrna, TNNPI 1578665188

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.8% of the total across 288 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Smith+Nephew accounts for 68.6% of it on its own, with 23 other manufacturers making up the rest.

$5,745in general payments, 2019–2025

Across 288 payments — averaging $19.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$4K
  • Kerecis Limited$274
  • Paratek Pharmaceuticals, Inc.$256
  • Organogenesis Inc.$252
  • Lifenet Health$176
  • AbbVie$156
  • plus $688 from 18 others

What the payments were for

  • Travel & lodging$90%
  • Food & beverage$5,736100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,745 in reported general payments places this provider in the 75th percentile of 105 podiatrist providers in Tennessee.

See all podiatrist providers in Tennessee

Medicare billing

Part B allowed, 2024
$142,716
Medicare patients
249
Services billed
2,296

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ammonium Lactate150$3,248
Diclofenac Sodium82$2,364
Ketoconazole62$1,214
Terbinafine Hcl37$543
Triamcinolone Acetonide33$389
Cephalexin35$271
Ciprofloxacin Hcl32$269
Silver Sulfadiazine20$252
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen33$189
Methylprednisolone16$186
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim45$179
Indomethacin11$123
Doxycycline Hyclate12$107
Prednisone11$49
Meloxicam15$43

Paid to pharmacies, not to this prescriber.

Other podiatrist in Smyrna

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →